CBIZ Investment Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$373K Sell
406
-175
-30% -$177K 0.01% 36
2025
Q4
$625K Buy
581
+60
+12% +$57.4K 0.02% 32
2025
Q3
$398K Sell
521
-5
-1% -$3.72K 0.02% 38
2025
Q2
$410K Sell
526
-22
-4% -$17.1K 0.02% 35
2025
Q1
$453K Buy
548
+68
+14% +$56.6K 0.02% 34
2024
Q4
$371K Sell
480
-37
-7% -$30.6K 0.02% 38
2024
Q3
$458K Hold
517
0.02% 32
2024
Q2
$468K Sell
517
-100
-16% -$80K 0.03% 30
2024
Q1
$480K Buy
617
+97
+19% +$69K 0.03% 31
2023
Q4
$303K Buy
520
+125
+32% +$73K 0.02% 36
2023
Q3
$212K Buy
+395
New +$204K 0.02% 31
2021
Q3
Hold
0
52
2021
Q2
Hold
0
51
2021
Q1
Hold
0
47
2020
Q4
Hold
0
50
2020
Q3
Hold
0
53
2020
Q2
Hold
0
52
2020
Q1
Hold
0
61
2019
Q4
Hold
0
75

Other funds holding LLY

CBIZ Investment Advisory Services's LLY Position: Q1 2026 in Review

CBIZ Investment Advisory Services reduced its Eli Lilly (LLY) stake by 30% in Q1 2026, selling an estimated $177K and leaving 406 shares worth $373K. The position accounts for 0.01% of the portfolio, ranked #36.

CBIZ Investment Advisory Services first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $625K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • CBIZ Investment Advisory Services held 406 shares of Eli Lilly worth $373K as of Q1 2026.
  • CBIZ Investment Advisory Services sold 175 Eli Lilly shares in Q1 2026, an estimated $177K.
  • Eli Lilly made up 0.01% of CBIZ Investment Advisory Services's portfolio in Q1 2026, its #36 holding.
  • CBIZ Investment Advisory Services first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • CBIZ Investment Advisory Services's Eli Lilly position peaked at $625K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on CBIZ Investment Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.